BusinessAgile Therapeutics Reports Additional Phase 3 SECURE Study Results Relating to Twirla® at ACOG 2017By Nasdaq OMXMay 6, 2017, 6:05 PM UTC
BusinessAgile Therapeutics Announces Presentation of SECURE Phase 3 Data at the 2017 Congress on Women’s HealthBy Nasdaq OMXApr 27, 2017, 11:31 AM UTC
BusinessAgile Therapeutics Reports Fourth Quarter and Full Year 2016 Financial ResultsBy Nasdaq OMXMar 8, 2017, 9:15 PM UTC
